2nd Covalent Drug Discovery & Development Summit
Discover & Develop Selective, Clinically Validated & Novel Covalent Therapeutics to Expand the Targetable Proteome & Non-Cystine Amino Acid Space in Oncology, Immunology & Beyond
The covalency renaissance continues as biopharma race to unlock hard-to-target proteins across oncology, immunology and CNS. Yet, key challenges remain in balancing reactivity and sensitivity, de-risking the ligandability of alternative residues, and tackling PKPD disconnects and efficiency bottlenecks.
Bringing together 100+ covalency experts, the 2nd Covalent Drug Discovery & Development Summit returns as the only dedicated forum to comprehensively cover discovery to translation and clinical development of covalent therapeutics.
Dates: December 10-12, 2024
Location: Hilton Boston Logan Airport, Boston, Massachusetts
Event Program: https://ter.li/8obkjw
Dive into extensive technical content spanning target selectivity, hit screening, lead optimization and covalent warhead design, network with over 100 heads, directors and VPs of Proteomics, Medicinal Chemistry, Chemical Biology, Discovery Biology and Pharmacology, and hear from the brightest minds of academia as they share their latest findings.
Download the program here: https://ter.li/8obkjw
Register your place here (and take advantage of group discounts of up to 20% when registering your team of three or more!): https://ter.li/itylir
